Molecular and Cellular Mechanisms of Gynecologic Malignancies, Benign Diseases 2.0

Dear Colleagues,

Women's health is a major topic of concern all over the world. During their lives, women may encounter the invasion of gynecologic malignancies, including ovarian cancer, cervical cancer, uterine corpus, and endometrial cancer, many of which may be unexpected and have huge consequences on patients and their families. Gynecologic malignancies per se and relevant complications significantly influence the life span and quality of affected women. Other benign gynecologic diseases, such as endometriosis and polycystic ovary syndrome (PCOS), can bring about negative effects in women's daily lives. Healthcare related to these conditions has been an important issue and remains to be explored. This Special Issue plans to provide an overview of the most recent advances in the underlying molecular and cellular mechanisms of gynecologic malignancies, benign diseases. It solicits any original contributions and reviews that explore the nature of gynecologic malignancies and benign diseases, associated therapies, and health impacts on women in different countries and communities. Studies discussing the health issues mentioned above are suitable for consideration in the Special Issue. Advances in or any cutting-edge research on affected women’s healthcare are especially welcomed to be published. The listed topics suggest just a few of the many possibilities. Potential topics include, but are not limited to, gynecologic malignancies, endometrial cancer, ovarian cancer, cervical cancer, uterine cancer, chemotherapy, target therapy, tumor markers, benign gynecologic diseases, endometriosis, and polycystic ovary syndrome.

You may find related papers collected in the Special Issue below:
https://www.mdpi.com/journal/ijms/special_issues/Gynecologic_Malignancies

Dr. Kuo-Hu Chen
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• gynecologic malignancies
• endometrial cancer
• ovarian cancer
• cervical cancer
• uterine cancer
• chemotherapy
• target therapy
• tumor marker
• benign gynecologic diseases
• endometriosis
• polycystic ovary syndrome